CWG-59r

N/A

Report date: 2023/02/26 21:49:40

Base Information

Drug NameCWG-59r
Drug Alias NameCWG-59rCWG-59-rCWG59r
ClassificationBiologics
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesCellworks Group
China Registration ClassN/A

Develop Information

Active CompaniesCellworks Group
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A